Page last updated: 2024-09-03

ru 24926 and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

ru 24926 has been researched along with 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine in 1 studies

Compound Research Comparison

Studies
(ru 24926)
Trials
(ru 24926)
Recent Studies (post-2010)
(ru 24926)
Studies
(1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine)
Trials
(1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine)
Recent Studies (post-2010) (1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine)
30006405

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costentin, J; Panissaud, C; Simon, P1

Other Studies

1 other study(ies) available for ru 24926 and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

ArticleYear
Anxiogenic-like effects induced by stimulation of dopamine receptors.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:3

    Topics: Animals; Anxiety; Benzazepines; Carbolines; Dextroamphetamine; Diazepam; Dopamine Agents; Dopamine Antagonists; Haloperidol; Male; Mice; Motor Activity; Pentylenetetrazole; Phenethylamines; Piperazines; Receptors, Dopamine; Receptors, Dopamine D1; Yohimbine

1993